annual total liabilities:
$107.12M+$48.42M(+82.47%)Summary
- As of today (September 17, 2025), NAMS annual total liabilities is $107.12 million, with the most recent change of +$48.42 million (+82.47%) on December 31, 2024.
- During the last 3 years, NAMS annual total liabilities has risen by +$99.26 million (+1262.05%).
- NAMS annual total liabilities is now at all-time high.
Performance
NAMS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$36.62M-$4.43M(-10.80%)Summary
- As of today (September 17, 2025), NAMS quarterly total liabilities is $36.62 million, with the most recent change of -$4.43 million (-10.80%) on June 30, 2025.
- Over the past year, NAMS quarterly total liabilities has dropped by -$22.64 million (-38.20%).
- NAMS quarterly total liabilities is now -65.82% below its all-time high of $107.12 million, reached on December 31, 2024.
Performance
NAMS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NAMS Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +82.5% | -38.2% |
3 y3 years | +1262.0% | +419.7% |
5 y5 years | +763.3% | +195.1% |
NAMS Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1262.0% | -65.8% | +199.8% |
5 y | 5-year | at high | +1262.0% | -65.8% | +506.8% |
alltime | all time | at high | +1262.0% | -65.8% | +506.8% |
NAMS Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $36.62M(-10.8%) |
Mar 2025 | - | $41.05M(-61.7%) |
Dec 2024 | $107.12M(+82.5%) | $107.12M(+77.6%) |
Sep 2024 | - | $60.33M(+1.8%) |
Jun 2024 | - | $59.25M(-22.7%) |
Mar 2024 | - | $76.66M(+527.7%) |
Dec 2023 | $58.70M(+21.2%) | - |
Dec 2022 | $48.43M | - |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $12.21M(+73.3%) |
Jun 2022 | - | $7.05M(+16.8%) |
Mar 2022 | - | $6.03M(-23.3%) |
Dec 2021 | $7.86M(-36.6%) | $7.86M(-4.9%) |
Sep 2021 | - | $8.27M(-19.2%) |
Jun 2021 | - | $10.24M(+9.3%) |
Mar 2021 | - | $9.36M(-24.5%) |
Dec 2020 | $12.41M | $12.41M |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual total liabilities?
- What is the all time high annual total liabilities for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual total liabilities year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly total liabilities?
- What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly total liabilities year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual total liabilities?
The current annual total liabilities of NAMS is $107.12M
What is the all time high annual total liabilities for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual total liabilities is $107.12M
What is NewAmsterdam Pharma Company N.V. annual total liabilities year-on-year change?
Over the past year, NAMS annual total liabilities has changed by +$48.42M (+82.47%)
What is NewAmsterdam Pharma Company N.V. quarterly total liabilities?
The current quarterly total liabilities of NAMS is $36.62M
What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly total liabilities is $107.12M
What is NewAmsterdam Pharma Company N.V. quarterly total liabilities year-on-year change?
Over the past year, NAMS quarterly total liabilities has changed by -$22.64M (-38.20%)